Heartbeam, Inc. Common Stock
BEATHeartBeam, Inc. (BEAT) is a healthcare technology company specializing in developing artificial intelligence-powered cardiovascular monitoring solutions. The company focuses on creating innovative, outpatient cardiac assessment tools that allow for early detection, diagnosis, and management of heart conditions, aiming to improve patient outcomes through advanced remote monitoring and analysis.
Company News
Five companies—VentriPoint Diagnostics, HeartBeam, Heartflow, Hyperfine, and GE Healthcare Technologies—are advancing AI-enabled cardiac diagnostic platforms to address the global heart disease crisis. Recent developments include VentriPoint's partnership with First Light Health for remote Indigenous communities, HeartBeam's collaboration wit...
A new report reveals the evolving cardiac diagnostics market, highlighting how consumer technology and medical systems are transforming heart monitoring, with a focus on intellectual property and diagnostic capabilities.
HeartBeam reported Q2 2025 results, showing a 23% decrease in cash burn and maintaining progress towards FDA clearance for its 12-lead ECG synthesis software, targeting a pilot launch in Florida and Southern California's concierge medical practices.
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program. FedEx reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.45 by 11.88% and represe...
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. National CineMedia, Inc. (NASDAQ: NCMI) climbed 81% to $0.2409 after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment. IMAC Holdings, Inc. (NASDAQ: BACK) gained 71% to $0.2144....
